Steven K. White,Igor Ivanisevic,Kyle Stephens,Mark Andres,Brenton Skylar Wolfe
申请号：
US16598694
公开号：
US20200190133A1
申请日:
2019.10.10
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Described herein are solid state 17α-ethynylandrost-5-ene-3β,7β,17β-triol including amorphous and crystalline forms and specific polymorphic forms thereof, and use of solid state 17α-ethynylandrost-5-ene-3β,7β,17β-triol in treating numerous diseases and disorders, including hyperglycemic conditions, such as type 2 diabetes and metabolic syndrome, autoimmune conditions, such as rheumatoid arthritis, ulcerative colitis and type 1 diabetes, among other inflammation related conditions, and neurodegenerative conditions in subjects or human patients.
